ARUN EKANT CHANDRA SHAW PROP INDEX NAV RESEARCH (INR) TRADING-INH000023737 shall disclose all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
i. Research analyst or research entity shall disclose the following in research report and in public appearance with regard to ownership and material conflicts of interest:
a. whether the research analyst or research entity or his associate or his relative has NOT any financial interest in the subject company and the nature of such financial interest;
b. whether the research analyst or research entity or its associates or relatives, have NOT actual/beneficial ownership of one per cent. or more securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
c. whether the research analyst or research entity or his associate or his relative, has NOT any other material conflict of interest at the time of publication of the research report or at the time of public appearance;
ii. Research analyst or research entity shall disclose the following in research report with regard to receipt of compensation:
a. whether it or its associates have NOT received any compensation from the subject company in the past twelve months;
b. whether it or its associates have NOT managed or co-managed public offering of securities for the subject company in the past twelve months;
c. whether it or its associates have NOT received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
d. whether it or its associates have NOT received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
e. whether it or its associates have NOT received any compensation or other benefits from the subject company or third party in connection with the research report.
iii. Research analyst or research entity shall disclose the following in public appearance with regard to receipt of compensation:
a. whether it or its associates have NOT received any compensation from the subject company in the past twelve months;
b. whether the subject company is NOT or was NOT a client during twelve months preceding the date of distribution of the research report and the types of services provided:
Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
iv. whether the research analyst has NOT served as an officer, director or employee of the subject company;
v. whether the research analyst or research entity has NOT been engaged in market making activity for the subject company;
vi. Research analyst or research entity shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.
• We are SEBI Registered “Research Analyst” not “Investment Advisers.
• Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
• Investors are advised to act according to their risk appetite, we are not providing Investment Advisory Services.
• Market fluctuations may result in partial or total loss of investments under specific conditions. Market Risks refer to either partial or permanent loss on your investments or portfolio in certain or adverse market conditions or company events.
• Historical performance is not indicative of future results.
• Our advice may involve open positions; we may not provide stop-loss or target prices in our securities recommendations. This could lead to significant losses in adverse market conditions or due to company events. For safety, we recommend exiting positions with a 20% loss from either the buying or selling side.
• The Research Analyst does not guarantee the accuracy, results, or reliability of the content on its website, including aspects of merchantability, suitability, and non-infringement.
• There is no avenue for claiming losses incurred based on recommendations found in the research report/calls.
• Understanding the risks of Hero to Zero and Zero to Hero options calls is crucial, as these can involve significant capital risk and a high probability of total capital loss. It’s vital to invest in Futures and Options (F&O) trading calls according to your individual risk tolerance.
• We provide research analysis and specific securities recommendations but do not offer portfolio management services, personal account handling, profit sharing, or investment advisory services based on risk profiling.
• The research report is provided to registered clients and is based on facts and data considered true and reliable. The information is derived from publicly available data or other believed reliable sources. The report is meant for informational purposes only and does not constitute an offer or solicitation to buy, sell, hold, or subscribe for securities or other financial instruments.
• We are not liable for any loss or damage arising from nonchalant errors in the information presented in the research report or recommendations.
• Investors may lose their entire investment or portfolio under certain market conditions. It is essential to understand your risk appetite or consult financial advisors before acting on any recommendations.
• The research report does not take into account specific investment objectives, goals, or financial situations of individuals. Clients should act according to their risk tolerance and financial circumstances while being aware of the risks in capital markets.
• We uphold our responsibility for client data security, confidentiality, and compliance.
(Please report any unethical practices to our support/compliance team at inrtradingofficial@gmail.com or contact SEBI’s toll-free number: 1800 22 7575 or 1800 266 7575.)
**Explore our social media channels and website for comprehensive information regarding risks, disclosures, disclaimers, investor charter, complaint table, terms and conditions, refund policies, SEBI Research Analyst registration details, compliance officer information, and more.